Works matching DE "SELEGILINE"

Results: 281

Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from Turnera diffusa (Damiana).

Published in:

Molecules, 2019, v. 24, n. 4, p. 810, doi. 10.3390/molecules24040810

By:

Chaurasiya, Narayan D.;
Zhao, Jianping;
Pandey, Pankaj;
Doerksen, Robert J.;
Muhammad, Ilias;
Tekwani, Babu L.

Publication type:

Article

Selegiline induced differentiation of rat bone marrow mesenchymal stem cells to dopaminergic neurons in vitro.

Published in:

Pharmacia (0428-0296), 2023, v. 70, n. 4, p. 959, doi. 10.3897/pharmacia.70.e107909

By:

Altememy, Dhiya;
Ghasem Kashani, Maryam Haji;
Khosravian, Pegah

Publication type:

Article

How best to address these common movement disorders.

Published in:

Journal of Family Practice, 2011, v. 60, n. 12, p. 721

By:

Yaman, Aylin;
Akdeniz, Melahat;
Yaman, Hakan

Publication type:

Article

Pharmacological interventions in aging and age-associated disorders.

Published in:

Geriatrics & Gerontology International, 2007, v. 7, n. 2, p. 97, doi. 10.1111/j.1447-0594.2007.00377.x

By:

Kitani, Kenichi

Publication type:

Article

SELEGILINE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN: A DOUBLE BLIND RANDOMIZED AND CONTROLLED TRIAL.

Published in:: 2002
Publication type:: Conference Paper/Materials

DEPRENYL, A THERAPEUTIC AGENT FOR PARKINSON’S DISEASE, INHIBITS ARSENIC TOXICITY POTENTIATED BY GSH DEPLETION VIA INHIBITION OF JNK ACTIVATION.

Published in:

Journal of Toxicology & Environmental Health: Part A, 2004, v. 67, n. 23/24, p. 2013, doi. 10.1080/15287390490514732

By:

Sang Geon Kim;
Chang Ho Lee;
Jeong Weon Park

Publication type:

Article

PSYCHOPHARMACOLOGY COLUMN WHY CHOOSE SELEGILINE TRANSDERMAL SYSTEM FOR REFRACTORY DEPRESSION?

Published in:

Issues in Mental Health Nursing, 2007, v. 28, n. 2, p. 223, doi. 10.1080/01612840601096461

By:

Tobin, Mary

Publication type:

Article

Neuroprotective Effects of Selegiline Agent Methamphetamine-Prompted Mood-Related Behavior Disorder Mediated Via 5-HT<sub>2</sub> and D<sub>2</sub> Receptors.

Published in:

International Journal of Preventive Medicine, 2023, v. 14, n. 1, p. 1, doi. 10.4103/ijpvm.ijpvm_42_22

By:

Gholami, Mina;
Kaviani, Neda;
Motaghinejad, Majid;
Ulloa, Luis

Publication type:

Article

Selegiline: past, present and future perspectives.

Published in:: European Journal of Neurology, 2002, v. 9, p. 225, doi. 10.1111/j.1468-1331.2002.tb00056.x
Publication type:: Article

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.

Published in:

Nicotine & Tobacco Research, 2015, v. 17, n. 9, p. 1126, doi. 10.1093/ntr/ntu273

By:

Sarginson, Jane E.;
Killen, Joel D.;
Lazzeroni, Laura C.;
Fortmann, Stephen P.;
Ryan, Heather S.;
Ameli, Niloufar;
Schatzberg, Alan F.;
Murphy Jr., Greer M.

Publication type:

Article

Selegiline Reverses Aβ-Induced Cognitive Deficit in Male Mice.

Published in:

Neurochemical Research, 2013, v. 38, n. 11, p. 2287, doi. 10.1007/s11064-013-1137-6

By:

Pazini, Andréia;
Gomes, Guilherme;
Villarinho, Jardel;
Cunha, Claudio;
Pinheiro, Francielle;
Ferreira, Ana;
Mello, Carlos;
Ferreira, Juliano;
Rubin, Maribel

Publication type:

Article

Bacopa monnieri and l-Deprenyl Differentially Enhance the Activities of Antioxidant Enzymes and the Expression of Tyrosine Hydroxylase and Nerve Growth Factor via ERK 1/2 and NF-κB Pathways in the Spleen of Female Wistar Rats.

Published in:

Neurochemical Research, 2013, v. 38, n. 1, p. 141, doi. 10.1007/s11064-012-0902-2

By:

Priyanka, Hannah;
Bala, Preetam;
Ankisettipalle, Sindhu;
ThyagaRajan, Srinivasan

Publication type:

Article

R-Deprenyl: Pharmacological Spectrum of its Activity.

Published in:

Neurochemical Research, 2010, v. 35, n. 12, p. 1922, doi. 10.1007/s11064-010-0238-8

By:

Magyar, K.;
Szende, B.;
Jenei, V.;
Tábi, T.;
Pálfi, M.;
Szökő, É.

Publication type:

Article

Antiperoxidative and Antiinflammatory Effect of Sida Cordifolia Linn. on Quinolinic Acid Induced Neurotoxicity.

Published in:

Neurochemical Research, 2010, v. 35, n. 9, p. 1361, doi. 10.1007/s11064-010-0192-5

By:

Swathy, S. S.;
Panicker, Seema;
Nithya, R. S.;
Anuja, M. M.;
Rejitha, S.;
Indira, M.

Publication type:

Article

Interaction Between Warfarin and Transdermal Selegiline: First Case Report and Literature Review.

Published in:

Hospital Pharmacy, 2010, v. 45, n. 6, p. 478, doi. 10.1310/hpj4506-478

By:

Ensor, Christopher R.;
Dean, Stacey R.

Publication type:

Article

Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.

Published in:

Journal of Neurology, 2000, v. 247, n. 11, p. 868

By:

Haapaniemi, Tarja H.;
Kallio, Mika A.;
Korpelainen, Juha T.;
Suominen, Kalervo;
Tolonen, Uolevi;
Sotaniemi, Kyösti A.;
Myllylä, Vilho V.

Publication type:

Article

Workshop II: “Neuroprotection”– the Lugano consensus.

Published in:

Journal of Neurology, 2000, v. 247, p. IV36, doi. 10.1007/PL00007774

By:

Riederer, P.;
Brücke, T.;
M&umml;ller, T.;
Schwartz, A.;
Storch, A.;
Winner, B.

Publication type:

Article

An interesting case of serotonin syndrome precipitated by escitalopram.

Published in:

2010

By:

Sanyal, Debasish;
Chakraborty, Suddhendu;
Bhattacharyya, Ranjan

Publication type:

Case Study

Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach.

Published in:

Molecules, 2024, v. 29, n. 6, p. 1328, doi. 10.3390/molecules29061328

By:

Hu, Yuliang;
Bao, Jinping;
Tang, Dongyu;
Gao, Shushan;
Wang, Fei;
Ding, Zhongtao;
Cui, Chengsen

Publication type:

Article

Synergistic Effect of Lovastatin and Selegiline on the Differentiation of Bone Marrow Stromal Cells Into Neuron-Like Cells.

Published in:

Jentashapir Journal of Cellular & Molecular Biology, 2023, v. 14, n. 4, p. 1, doi. 10.5812/jjcmb-141092

By:

Abdanipour, Alireza;
Karami, Behnam;
Fridoni, Mohammad Javad;
Mohamadi, Momeneh;
Fakheri, Farzaneh

Publication type:

Article

Detection of l-Methamphetamine and l-Amphetamine as Selegiline Metabolites.

Published in:

Journal of Analytical Toxicology, 2021, v. 45, n. 1, p. 99, doi. 10.1093/jat/bkaa058

By:

Shin, Ilchung;
Choi, Hyeyoung;
Kang, Seojin;
Kim, Jihyun;
Park, Yuran;
Yang, Wonkyung

Publication type:

Article

Effect of l -Deprenyl and Gliclazide on Oxidant Stress/Antioxidant Status and DNA Damage in a Diabeticrat Model.

Published in:

Endocrine Research, 2005, v. 31, n. 3, p. 199, doi. 10.1080/07435800500371805

By:

Alper, Gulinnaz;
Irer, Seda;
Duman, Erdal;
Caglayan, Osman;
Yilmaz, Candeger

Publication type:

Article

The neuroprotective effect of selegiline in streptozotocin induced diabetic rats.

Published in:

Journal of Cellular Neuroscience & Oxidative Stress, 2018, v. 10, n. 2, p. 739

By:

Onur, Mehmet A. K.;
SEKKİN, Selim

Publication type:

Article

Improvement of Movement Disorder and Neurodevelopment under Selegiline in a CLTC‐Deficient Patient.

Published in:

Movement Disorders Clinical Practice, 2023, v. 10, n. 9, p. 1430, doi. 10.1002/mdc3.13834

By:

Nardecchia, Francesca;
Bove, Rossella;
Pollini, Luca;
Giannini, Maria Teresa;
Manti, Filippo;
De Giorgi, Agnese;
Papoff, Paola;
Martinelli, Simone;
Leuzzi, Vincenzo

Publication type:

Article

L-Deprenyl treatment in aged mice slightly increases life spans, and greatly reduces fecundity by...

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 1996, v. 51A, n. 6, p. B448, doi. 10.1093/gerona/51A.6.B448

By:

Archer, J.R.;
Harrison, D.E.

Publication type:

Article

Short intertrial intervals impair water maze performance in old Fischer 344 rats.

Published in:

1996

By:

Rick, J T;
Murphy, M P;
Ivy, G O;
Milgram, N W

Publication type:

journal article

Changes in vascular alpha1- and alpha2-adrenoceptor responsiveness by selegiline treatment.

Published in:

Fundamental & Clinical Pharmacology, 2001, v. 15, n. 4, p. 239, doi. 10.1046/j.1472-8206.2001.00036.x

By:

Pelat, M.;
Verwaerde, P.;
Tran, M.A.;
Berlan, M.;
Senard, J.M.;
Montastruc, J.L.

Publication type:

Article

Expression of neurotrophic factor genes by human adipose stem cells post-induction by deprenyl.

Published in:

Anatomy & Cell Biology, 2021, v. 54, n. 1, p. 74, doi. 10.5115/acb.19.229

By:

Amiri, Arezoo;
Ghasem Kashani, Maryam Haji;
Ghorbanian, Mohammad Taghi

Publication type:

Article

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder: A Viewpoint by Thomas C. Baghai.

Published in:

2007

By:

Baghai, Thomas C.

Publication type:

Editorial

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder: A Viewpoint by J. Alexander Bodkin.

Published in:

2007

By:

Bodkin, J. Alexander

Publication type:

Editorial

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder.

Published in:

Drugs, 2007, v. 67, n. 2, p. 257, doi. 10.2165/00003495-200767020-00006

By:

Frampton, James E.;
Plosker, Greg L.

Publication type:

Article

SELEGILINE IN THE TREATMENT OF BEHAVIOURAL DISTURBANCE IN ALZHEIMER'S DISEASE.

Published in:

International Journal of Geriatric Psychiatry, 1997, v. 12, n. 3, p. 319, doi. 10.1002/(SICI)1099-1166(199703)12:3<319::AID-GPS488>3.0.CO;2-Q

By:

Lawlor, Brian A.;
Aisen, Paul S.;
Green, Cynthia;
Fine, Elizabeth;
Scheidler, James

Publication type:

Article

Selegiline transdermal Patch (Eemsam) for Major Depressive Disorder.

Published in:

American Family Physician, 2008, v. 77, n. 4, p. 505

By:

Melton, Sarah;
Townsend, Charlotte Ann

Publication type:

Article

Benefits and Risks of Parkinson's Disease Drugs.

Published in:

American Family Physician, 2005, v. 71, n. 1, p. 144

By:

Shaughnessy, Allen F.

Publication type:

Article

Selegiline and vitamin E for Alzheimer's disease.

Published in:

American Family Physician, 1998, v. 57, n. 1, p. 147

By:

Andolsek, Kathryn M.

Publication type:

Article

Selegiline in the treatment of early Parkinson's disease.

Published in:: American Family Physician, 1996, v. 53, n. 5, p. 1866
Publication type:: Article

EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum].

Published in:: 2014
Publication type:: Correction Notice

Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson's Disease: A Network Meta-Analysis.

Published in:

European Neurology, 2024, v. 87, n. 5/6, p. 273, doi. 10.1159/000541315

By:

Wang, Yaping;
Wang, Zhiyun

Publication type:

Article

Treatment of Mild Camptocormia with Selegiline in Patients with Parkinson's Disease.

Published in:

European Neurology, 2016, v. 76, n. 1/2, p. 35, doi. 10.1159/000447631

By:

Yoritaka, asako;
Mori, Hideo;
Hattori, Nobutaka

Publication type:

Article

Pharmacokinetics and Absolute Bioavailability of Selegiline Following Treatment of Healthy Subjects With the Selegiline Transdermal System (6 mg/24 h): A Comparison With Oral Selegiline Capsules.

Published in:: Journal of Clinical Pharmacology, 2007, v. 47, n. 10, p. 1256, doi. 10.1177/0091270007304779
Publication type:: Article

Evaluation of the Potential for Pharmacodynamic and Pharmacokinetic Drug Interactions Between Selegiline Transdermal System and Two Sympathomimetic Agents (Pseudoephedrine and Phenylpropanolamine) in Healthy Volunteers.

Published in:: Journal of Clinical Pharmacology, 2007, v. 47, n. 8, p. 978, doi. 10.1177/0091270007302950
Publication type:: Article

Selegiline Transdermal System: An Examination of the Potential for CYP450- Dependent Pharmacokinetic Interactions With 3 Psychotropic Medications.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 2, p. 146, doi. 10.1177/0091270006296151

By:

Albert AJA Azzaro;
John JZ Ziemniak;
Eva EK Kemper;
Bryan BJC Campbell;
Chad CV VanDenBerg

Publication type:

Article

Selegiline Transdermal System (STS) as an Aid for Smoking Cessation.

Published in:

Nicotine & Tobacco Research, 2012, v. 14, n. 3, p. 377, doi. 10.1093/ntr/ntr143

By:

Kahn, Roberta;
Gorgon, Liza;
Jones, Karen;
McSherry, Frances;
Glover, Elbert D.;
Anthenelli, Robert M.;
Jackson, Thomas;
Williams, Jill;
Murtaugh, Cristin;
Montoya, Ivan;
Yu, Elmer;
Elkashef, Ahmed

Publication type:

Article

Effect of selegiline as a monomine oxidase B inhibitor on the expression of neurotrophin mRNA levels in a contusion rat model of spinal cord injury.

Published in:

Neurological Research, 2023, v. 45, n. 3, p. 241, doi. 10.1080/01616412.2022.2129761

By:

Abdanipour, Alireza;
Mirzaei, Mojgan;
Anarkooli, Iraj Jafari;
Mohammadi, Parvin

Publication type:

Article

A new tetracyclic saponin from Astragalus glycyphyllos L. and its neuroprotective and hMAO-B inhibiting activity.

Published in:

Natural Product Research, 2020, v. 34, n. 4, p. 511, doi. 10.1080/14786419.2018.1491040

By:

Shkondrov, Aleksandar;
Krasteva, Ilina;
Bucar, Franz;
Kunert, Olaf;
Kondeva-Burdina, Magdalena;
Ionkovaa, Iliana

Publication type:

Article

Selegiline may be harmful in early Parkinson's.

Published in:

Brown University Psychopharmacology Update, 1996, v. 7, n. 5, p. 3

By:

Lees, A.J.

Publication type:

Article

Antioxidant Properties, Neuroprotective Effects and in Vitro Safety Evaluation of New Pyrrole Derivatives.

Published in:

Pharmaceutical Chemistry Journal, 2022, v. 55, n. 12, p. 1310, doi. 10.1007/s11094-022-02577-3

By:

Tzankova, Diana;
Aluani, Denitsa;
Kondeva-Burdina, Magdalena;
Georgieva, Maya;
Vladimirova, Stanislava;
Peikova, Lily;
Tzankova, Virginia

Publication type:

Article

Experimental pharmacological research regarding the antidepressant effect of associating doxepin and selegiline in normal mice.

Published in:

Journal of Mind & Medical Sciences, 2019, v. 6, n. 2, p. 261, doi. 10.22543/7674.62.P261270

By:

Chiriţă, Cornel;
Ştefănescu, Emil;
Zbârcea, Cristina E.;
Mireşan, Horaţiu;
Negreş, Simona;
Nuţă, Diana C.;
Limban, Carmen;
Miulescu, Rucsandra E. Dănciulescu;
Marineci, Cristina D.

Publication type:

Article

Selegiline in Patients With Disorder of Consciousness: An Open Pilot Study.

Published in:

Canadian Journal of Neurological Sciences, 2018, v. 45, n. 6, p. 688, doi. 10.1017/cjn.2018.315

By:

Masotta, Orsola;
Trojano, Luigi;
Loreto, Vincenzo;
Moretta, Pasquale;
Estraneo, Anna

Publication type:

Article

Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2016, v. 44, n. 3, p. 865, doi. 10.3109/21691401.2014.998824

By:

Singh, Devendra;
Rashid, Muzamil;
Hallan, Supandeep Singh;
Mehra, Neelesh Kumar;
Prakash, Atish;
Mishra, Neeraj

Publication type:

Article